These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 34247254)
1. Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data. Hadji P; Schweikert B; Kloppmann E; Gille P; Joeres L; Toth E; Möckel L; Glüer CC Arch Gynecol Obstet; 2021 Sep; 304(3):703-712. PubMed ID: 34247254 [TBL] [Abstract][Full Text] [Related]
2. Risk of subsequent fracture after prior fracture among older women. Balasubramanian A; Zhang J; Chen L; Wenkert D; Daigle SG; Grauer A; Curtis JR Osteoporos Int; 2019 Jan; 30(1):79-92. PubMed ID: 30456571 [TBL] [Abstract][Full Text] [Related]
3. Risk of imminent fracture following a previous fracture in a Swedish database study. Banefelt J; Åkesson KE; Spångéus A; Ljunggren O; Karlsson L; Ström O; Ortsäter G; Libanati C; Toth E Osteoporos Int; 2019 Mar; 30(3):601-609. PubMed ID: 30680431 [TBL] [Abstract][Full Text] [Related]
4. Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures. Weycker D; Edelsberg J; Barron R; Atwood M; Oster G; Crittenden DB; Grauer A Osteoporos Int; 2017 Sep; 28(9):2565-2571. PubMed ID: 28593447 [TBL] [Abstract][Full Text] [Related]
5. Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Söreskog E; Ström O; Spångéus A; Åkesson KE; Borgström F; Banefelt J; Toth E; Libanati C; Charokopou M Bone; 2020 May; 134():115286. PubMed ID: 32070789 [TBL] [Abstract][Full Text] [Related]
6. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures. Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096 [TBL] [Abstract][Full Text] [Related]
7. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population. Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O Osteoporos Int; 2017 Aug; 28(8):2485-2494. PubMed ID: 28536737 [TBL] [Abstract][Full Text] [Related]
8. Real-world effectiveness of osteoporosis treatments in Germany. O'Kelly J; Bartsch R; Kossack N; Borchert J; Pignot M; Hadji P Arch Osteoporos; 2022 Aug; 17(1):119. PubMed ID: 36044096 [TBL] [Abstract][Full Text] [Related]
9. Fragility fractures and imminent fracture risk in Hong Kong: one of the cities with longest life expectancies. Wong RMY; Ho WT; Wai LS; Li W; Chau WW; Chow KS; Cheung WH Arch Osteoporos; 2019 Oct; 14(1):104. PubMed ID: 31659457 [TBL] [Abstract][Full Text] [Related]
10. The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden. Lorentzon M; Litsne H; Axelsson KF Osteoporos Int; 2024 Jun; 35(6):1077-1087. PubMed ID: 38521820 [TBL] [Abstract][Full Text] [Related]
11. Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database. Fujiwara S; Buchanan-Hughes A; Ng A; Page J; Adachi K; Li H Osteoporos Int; 2022 Oct; 33(10):2205-2216. PubMed ID: 35779100 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study. Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394 [TBL] [Abstract][Full Text] [Related]
13. Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older. van der Velde RY; Wyers CE; Geusens PPMM; van den Bergh JPW; de Vries F; Cooper C; van de Staa TP; Harvey NC Osteoporos Int; 2018 Nov; 29(11):2469-2475. PubMed ID: 30030587 [TBL] [Abstract][Full Text] [Related]
14. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women. Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575 [TBL] [Abstract][Full Text] [Related]
15. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States. Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555 [TBL] [Abstract][Full Text] [Related]
16. Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171 [TBL] [Abstract][Full Text] [Related]
17. Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Barron RL; Oster G; Grauer A; Crittenden DB; Weycker D Osteoporos Int; 2020 Nov; 31(11):2103-2111. PubMed ID: 32613410 [TBL] [Abstract][Full Text] [Related]
18. The imminent risk of a fracture-existing worldwide data: a systematic review and meta-analysis. Wong RMY; Wong PY; Liu C; Wong HW; Chung YL; Chow SKH; Law SW; Cheung WH Osteoporos Int; 2022 Dec; 33(12):2453-2466. PubMed ID: 35776148 [TBL] [Abstract][Full Text] [Related]
19. Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Schemitsch E; Adachi JD; Brown JP; Tarride JE; Burke N; Oliveira T; Slatkovska L Osteoporos Int; 2022 Jan; 33(1):113-122. PubMed ID: 34379148 [TBL] [Abstract][Full Text] [Related]
20. The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Gibson-Smith D; Klop C; Elders PJ; Welsing PM; van Schoor N; Leufkens HG; Harvey NC; van Staa TP; de Vries F Osteoporos Int; 2014 Nov; 25(11):2555-63. PubMed ID: 25001987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]